Tauns Laboratories Inc
TSE:197A

Watchlist Manager
Tauns Laboratories Inc Logo
Tauns Laboratories Inc
TSE:197A
Watchlist
Price: 521 JPY -6.8% Market Closed
Market Cap: ¥55.4B

Tauns Laboratories Inc
Investor Relations

TAUNS Laboratories, Inc. develops and manufactures vitro diagnostic drugs & measuring instruments. The company is headquartered in Izunokuni-Shi, Shizuoka-Ken and currently employs 316 full-time employees. The company went IPO on 2024-06-20. The firm operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Contacts

Address
SHIZUOKA-KEN
Izunokuni-shi
761-1, Kamishima
Contacts
+81558768181
www.tauns.co.jp